How does myTomorrows support expanded access programs?

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

1 mins read

share this post

We guide BioPharma companies through developing expanded access strategies up to full EAP execution and preparation for full commercial launch. We have experience in a wide range of expanded access use cases, across different regions and therapeutics areas:

free-of-charge or paid-for
single patient or cohort programs
post-trial access

Conducting expanded access programs on behalf of our clients is our core expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain, Real-World Data, and Pharmacovigilance.

share this post

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

more articles

view all blogs

myTomorrows Avego finding announcement

Our next chapter: €25M growth investment to scale patient access worldwide

Michel van Harten

11 Nov 2025

7 mins read

ALS patient flow

Accelerating ALS Clinical Trial Recruitment in the U.S.

Dennis Akkaya

10 Oct 2025

12 mins read

Vanessa Lemarie

myTomorrows’ COO Vanessa Lemarié Named in Sifted’s Top 100 Women in Tech Europe

Michel van Harten

10 Oct 2025

2 mins read

Smarter Clinical Trial Recruitment that Delivers Faster Site Enrollment

Dennis Akkaya

18 Sep 2025

10 mins read

Woman with Multiple System Atrophy using a cane to walk

Exploring the Symptoms of Multiple System Atrophy

Andrea Enguita

13 Aug 2025

15 mins read

James Griffin sickle cell patient advocate

Treatment Advances and Patient Advocacy in Sickle Cell Disease: A Conversation with James Griffin

John Massarelli

7 Aug 2025

10 mins read

Searching for Solutions: How Physicians Navigate Trial Access and Technology

Michel van Harten

17 Jul 2025

4 mins read

Older woman walking with the help of a walker

Multiple System Atrophy: Understanding the Condition

Andrea Enguita

23 Jun 2025

15 mins read

Why A Purpose-Built Platform for Expanded Access Management Matters

Dennis Akkaya

28 May 2025

7 mins read

myTomorrows Surpasses 15,000 Patient Matches through AI-Powered Platform and Personalized Services

myTomorrows Team

20 May 2025

3 mins read